Yi Chen Analyst PerformanceManaging Director of Equity Research at HC WainwrightYi Chen is a stock analyst at HC Wainwright focused in the medical sector, covering 70 publicly traded companies. Over the past year, Yi Chen has issued 115 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yi Chen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yi Chen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings468 Last 10 YearsBuy Recommendations90.89% 419 Buy RatingsCompanies Covered70 Unique Companies Ratings Distribution461RatingsDistribution of strong buy, buy, hold, and sell ratings by Yi Chen.RatingPercentageCount Strong Buy0.4%2 ratings Buy90.5%417 ratings Hold9.1%42 ratings Sell0.0%0 ratingsOut of 461 total stock ratings issued by Yi Chen at HC Wainwright, the majority (90.5%) have been Buy recommendations, followed by 9.1% Hold and 0.4% Strong Buy.Best & Worst CallsBest Call000000.0%CODXJun 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%KALAMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ87.1% of companies on NASDAQ61 companiesOTCMKTS7.1% of companies on OTCMKTS5 companiesNYSEAMERICAN4.3% of companies on NYSEAMERICAN3 companiesNYSE1.4% of companies on NYSE1 companyYi Chen, an analyst at HC Wainwright, currently covers 70 companies listed on NASDAQ, OTCMKTS, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical65 companies92.9%Manufacturing2 companies2.9%Miscellaneous1 company1.4%Industrials1 company1.4%Computer and Technology1 company1.4%Yi Chen of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE21 companies30.0%MED - DRUGS10 companies14.3%MED INSTRUMENTS9 companies12.9%PHARMACEUTICAL PREPARATIONS8 companies11.4%MEDICAL SERVICES5 companies7.1%MED PRODUCTS4 companies5.7%SURGICAL & MEDICAL INSTRUMENTS3 companies4.3%MEDICAL INFO SYS2 companies2.9%MEDICAL LABORATORIES2 companies2.9%Miscellaneous1 company1.4%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company1.4%PROTECTION - SFTY1 company1.4%BIOTECHNOLOGY1 company1.4%MED/DENTAL - SUPP1 company1.4%ELECTRONIC COMPUTER MANUFACTURING1 company1.4% About Yi ChenDr. Chen is a Managing Director of Equity Research at H.C. Wainwright with expertise in both the biotechnology and the pharmaceutical sectors. Dr. Chen’s research covers investment opportunities in the U.S. healthcare industry. Prior to joining H.C. Wainwright, Dr. Chen worked as an Associate Director of Equity Research at Aegis Capital Corp. and as a Research Associate at Morgan Joseph TriArtisan, LLC. Dr. Chen also worked as a Trading Associate at Zhang Capital Management, a New York-based buy-side fund. Prior to that, Dr. Chen was a Research Associate at the City University of New York where his research focused primarily on protein signaling domains utilizing an RNA interference approach. Dr. Chen published several articles in leading peer-reviewed journals, presented research at various scientific conferences, and taught biology courses at Hunter College in New York City. Dr. Chen’s educational background includes a Ph.D. in biochemistry from the City University of New York and a B.S. in Biophysics from Fudan University. Dr. Chen is also a Chartered Financial Analyst (CFA) charterholder.Follow on LinkedIn Yi Chen's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLFMDLifeMD5/26/2026Reiterated Rating$4.37$10.00Buy$0.0000.00% ROIBEATHeartBeam5/22/2026Lower Price Target$0.92$2.50Buy$0.0000.00% ROIBLTEBelite Bio5/21/2026Reiterated Rating$143.36$200.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical5/20/2026Reiterated Rating$10.68$15.00Buy$0.0000.00% ROIPMIPMI5/18/2026Initiated Coverage$0.16Neutral$0.0000.00% ROINPCENeuroPace5/15/2026Boost Price Target$15.19$20.00Buy$0.0000.00% ROIOBIOOrchestra BioMed5/14/2026Reiterated Rating$4.06$10.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical5/12/2026Boost Price Target$10.34$15.00Buy$0.0000.00% ROIOCSOculis5/12/2026Boost Price Target$30.50$47.00Buy$0.0000.00% ROITEMTempus AI5/11/2026Lower Price Target$49.86$64.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AXGNAxoGen4/29/2026Boost Price Target$41.99$50.00Buy$0.0000.00% ROIBLTEBelite Bio4/22/2026Reiterated Rating$165.23$200.00Buy$0.0000.00% ROIOCSOculis4/20/2026Reiterated Rating$28.94$44.00Buy$0.0000.00% ROIVVOSVivos Therapeutics4/17/2026Lower Price Target$1.02$2.50Buy$0.0000.00% ROIBNGOBionano Genomics4/13/2026Lower Price Target$1.13$6.00Buy$0.0000.00% ROIBLTEBelite Bio4/13/2026Reiterated Rating$172.76$200.00Buy$0.0000.00% ROIOCULOcular Therapeutix4/13/2026Reiterated Rating$8.79$21.00Buy$0.0000.00% ROILPCNLipocine4/6/2026Reiterated Rating$2.05Neutral$0.0000.00% ROIVNRXVolitionRX4/2/2026Lower Price Target$3.52$20.00Buy$0.0000.00% ROICOCHEnvoy Medical3/31/2026Initiated Coverage$0.64$2.50Buy$0.0000.00% ROIVANIVivani Medical3/31/2026Lower Price Target$1.00$3.50Buy$0.0000.00% ROIHROWHarrow3/19/2026Reiterated Rating$34.48$70.00Buy$0.0000.00% ROIBEATHeartBeam3/16/2026Reiterated Rating$1.36$5.50Buy$0.0000.00% ROILFMDLifeMD3/11/2026Boost Price Target$3.91$10.00Buy$0.0000.00% ROISGPSpyglass Pharma3/10/2026Initiated Coverage$27.12$37.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical3/10/2026Reiterated Rating$6.81$12.00Buy$0.0000.00% ROIRGNXREGENXBIO3/9/2026Lower Price Target$8.65$30.00Buy$0.0000.00% ROITEMTempus AI3/9/2026Boost Price Target$50.32$95.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/5/2026Boost Price Target$18.00$30.00Buy$0.0000.00% ROIHROWHarrow3/4/2026Boost Price Target$38.60$70.00Buy$0.0000.00% ROIOCSOculis3/4/2026Boost Price Target$27.99$44.00Buy$0.0000.00% ROIBLTEBelite Bio3/3/2026Boost Price Target$180.09$200.00Buy$0.0000.00% ROIBLCOBausch + Lomb2/23/2026Boost Price Target$17.79$20.00Buy$0.0000.00% ROIRGNXREGENXBIO2/10/2026Lower Price Target$8.92$32.00Buy$0.0000.00% ROIOKYOOKYO Pharma1/29/2026Reiterated Rating$2.04$7.00Buy$0.0000.00% ROIRGNXREGENXBIO1/29/2026Reiterated Rating$11.50$34.00Buy$0.0000.00% ROIBLTEBelite Bio1/28/2026Reiterated Rating$167.34$185.00Buy$0.0000.00% ROINPCENeuroPace1/27/2026Boost Price Target$16.23$19.00Buy$0.0000.00% ROISMTISanara MedTech1/26/2026Reiterated Rating$20.98$36.00Buy$0.0000.00% ROILPCNLipocine1/21/2026Reiterated Rating$9.92$15.00Buy$0.0000.00% ROIALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoidVRAXVirax Biolabs Group1/9/2026Reiterated Rating$0.38$1.00Buy$0.0000.00% ROIGLSIGreenwich LifeSciences12/30/2025Boost Price Target$24.78$50.00Buy$0.0000.00% ROIBLFSBioLife Solutions12/29/2025Reiterated Rating$24.90$32.00Buy$0.0000.00% ROILEXXLexaria Bioscience12/26/2025Lower Price Target$0.56$1.50Buy$0.0000.00% ROIBEATHeartBeam12/11/2025Reiterated Rating$2.01Speculative Buy$0.0000.00% ROIBEATHeartBeam12/11/2025Set Price Target$2.23$5.50$0.0000.00% ROIBEATHeartBeam12/10/2025Set Price Target$1.54$5.50$0.0000.00% ROIDRTSAlpha Tau Medical12/10/2025Reiterated Rating$4.71Buy$0.0000.00% ROIOCULOcular Therapeutix12/8/2025Boost Price Target$12.58$21.00Buy$0.0000.00% ROIBEATHeartBeam12/8/2025Initiated Coverage$0.72$2.50Buy$0.0000.00% ROIBEATHeartBeam12/8/2025Initiated Coverage$0.79$2.50Buy$0.0000.00% ROIAXGNAxoGen12/5/2025Boost Price Target$33.58$39.00Buy$0.0000.00% ROIBLTEBelite Bio12/1/2025Boost Price Target$150.72$185.00Buy$0.0000.00% ROIOCULOcular Therapeutix11/25/2025Reiterated Rating$12.10$19.00Buy$0.0000.00% ROIBLFSBioLife Solutions11/24/2025Reiterated Rating$26.53$32.00Buy$0.0000.00% ROIBNGOBionano Genomics11/24/2025Reiterated Rating$1.62$7.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical11/24/2025Reiterated Rating$3.82$9.00Buy$0.0000.00% ROICODXCo-Diagnostics11/24/2025Reiterated Rating$0.35Neutral$0.0000.00% ROILFMDLifeMD11/19/2025Lower Price Target$3.98$9.00Buy$0.0000.00% ROIVVOSVivos Therapeutics11/17/2025Initiated Coverage$2.34$7.00Buy$0.0000.00% ROIBRNSBarinthus Biotherapeutics11/17/2025Boost Price Target$0.80$4.00Buy$0.0000.00% ROIVNRXVolitionRX11/17/2025Lower Price Target$6.30$30.00Buy$0.0000.00% ROISMTISanara MedTech11/14/2025Lower Price Target$19.61$36.00Buy$0.0000.00% ROILPCNLipocine11/13/2025Lower Price Target$2.92$7.00Buy$0.0000.00% ROIHROWHarrow11/12/2025Boost Price Target$38.74$69.00Buy$0.0000.00% ROIOCSOculis11/11/2025Boost Price Target$19.42$42.00Buy$0.0000.00% ROITEMTempus AI11/7/2025Lower Price Target$72.09$89.00Buy$0.0000.00% ROIEDSAEdesa Biotech11/3/2025Reiterated Rating$1.77$5.00Buy$0.0000.00% ROIBLCOBausch + Lomb10/31/2025Boost Price Target$15.20$17.00Buy$0.0000.00% ROIAXGNAxoGen10/30/2025Boost Price Target$22.62$26.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical10/22/2025Reiterated Rating$4.18$9.00Buy$0.0000.00% ROIOCULOcular Therapeutix10/8/2025Boost Price Target$11.52$19.00Buy$0.0000.00% ROIOCSOculis10/7/2025Boost Price Target$18.56$36.00Buy$0.0000.00% ROIICCMIceCure Medical10/7/2025Boost Price Target$1.00$2.50Buy$0.0000.00% ROIRGNXREGENXBIO10/7/2025Reiterated Rating$10.69$34.00Buy$0.0000.00% ROIAXGNAxoGen9/30/2025Initiated Coverage$17.26$25.00Buy$0.0000.00% ROIVNRXVolitionRX9/30/2025Reiterated Rating$12.46$50.00Buy$0.0000.00% ROIAXGNAxoGen9/30/2025Initiated Coverage$17.84$25.00Buy$0.0000.00% ROIHROWHarrow9/29/2025Reiterated Rating$47.10$64.00Buy$0.0000.00% ROIKALAKALA BIO9/29/2025Reiterated Rating$2.13Neutral$0.0000.00% ROIOKYOOKYO Pharma9/23/2025Reiterated Rating$2.25$7.00Buy$0.0000.00% ROIKALAKALA BIO9/17/2025Boost Price Target$916.00$1,750.00Buy$0.0000.00% ROIBLTEBelite Bio9/15/2025Lower Price Target$69.48$98.00Buy$0.0000.00% ROITEMTempus AI9/12/2025Boost Price Target$88.78$98.00Buy$0.0000.00% ROIANIXAnixa Biosciences9/11/2025Reiterated Rating$3.02$7.00Buy$0.0000.00% ROITRMLTourmaline Bio9/10/2025Downgrade$47.64$48.00Neutral$0.0000.00% ROIRGNXREGENXBIO9/8/2025Reiterated Rating$9.71$34.00Buy$0.0000.00% ROIOBIOOrchestra BioMed9/4/2025Lower Price Target$2.72$10.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical9/3/2025Reiterated Rating$3.48$9.00Buy$0.0000.00% ROIKPRXKiora Pharmaceuticals9/2/2025Reiterated Rating$2.78$10.00Buy$0.0000.00% ROIBefore you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listingTEMTempus AI9/2/2025Initiated Coverage$75.86$90.00Buy$0.0000.00% ROIVANIVivani Medical9/2/2025Reiterated Rating$1.15$4.00Buy$0.0000.00% ROIELDNEledon Pharmaceuticals9/2/2025Reiterated Rating$2.59$9.00Buy$0.0000.00% ROIOCSOculis8/22/2025Boost Price Target$17.80$33.00Buy$0.0000.00% ROILPCNLipocine8/20/2025Reiterated Rating$2.96$8.00Buy$0.0000.00% ROIRGNXREGENXBIO8/19/2025Reiterated Rating$8.71$34.00Buy$0.0000.00% ROISMTISanara MedTech8/18/2025Boost Price Target$29.68$54.00Buy$0.0000.00% ROIBNGOBionano Genomics8/18/2025Reiterated Rating$3.04$11.00Buy$0.0000.00% ROISMTISanara MedTech8/18/2025Boost Price Target$29.68$54.00Buy$0.0000.00% ROIICCMIceCure Medical8/15/2025Lower Price Target$0.84$2.00Buy$0.0000.00% ROIHROWHarrow8/13/2025Boost Price Target$34.83$64.00Buy$0.0000.00% ROISRTSSensus Healthcare8/12/2025Lower Price Target$3.18$8.00Buy$0.0000.00% ROIBLFSBioLife Solutions8/8/2025Reiterated Rating$20.64$32.00Buy$0.0000.00% ROILFMDLifeMD8/7/2025Lower Price Target$6.53$13.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/6/2025Boost Price Target$10.52$23.00Buy$0.0000.00% ROIZYXIZynex8/1/2025Downgrade$2.23Neutral$0.0000.00% ROIBLCOBausch + Lomb7/31/2025Boost Price Target$13.60$16.00Buy$0.0000.00% ROILEXXLexaria Bioscience7/29/2025Lower Price Target$0.90$4.00Buy$0.0000.00% ROICLSDClearside Biomedical7/18/2025Downgrade$9.03$75.00Neutral$0.0000.00% ROIANGOAngioDynamics7/16/2025Reiterated Rating$8.49$16.00Buy$0.0000.00% ROIBLTEBelite Bio7/3/2025Reiterated Rating$56.81$100.00Buy$0.0000.00% ROILEXXLexaria Bioscience7/1/2025Lower Price Target$0.87$5.00Buy$0.0000.00% ROIZYXIZynex6/30/2025Reiterated Rating$2.62$8.00Buy$0.0000.00% ROIEDSAEdesa Biotech6/27/2025Upgrade$2.02$5.00Strong-Buy$0.0000.00% ROIELDNEledon Pharmaceuticals6/18/2025Upgrade$2.81$9.00Buy$0.0000.00% ROILPCNLipocine5/29/2025Upgrade$3.39$8.00Strong-Buy$0.0000.00% ROIOCULOcular Therapeutix5/29/2025Reiterated Rating$8.03$15.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals5/29/2025Reiterated Rating$7.05$22.00Buy$00.0000.00% ROIICCMIceCure Medical5/29/2025Reiterated Rating$1.04$2.50Buy$0.0000.00% ROINPCENeuroPace5/28/2025Initiated Coverage$12.66$18.00Buy$00.0000.00% ROIKALAKALA BIO5/23/2025Lower Price Target$204.50$600.00Buy$0.0000.00% ROICLSDClearside Biomedical5/23/2025Lower Price Target$12.80$75.00Buy$0.0000.00% ROIVANIVivani Medical5/19/2025Reiterated Rating$1.03$4.00Buy$0.0000.00% ROIBLTEBelite Bio5/15/2025Reiterated Rating$61.60$100.00Buy$000.0000.00% ROIBLFSBioLife Solutions5/13/2025Reiterated Rating$23.89$30.00Buy$00.0000.00% ROICDNACareDx5/5/2025Reiterated Rating$15.00$25.00Neutral$00.0000.00% ROIOKYOOKYO Pharma5/5/2025Reiterated Rating$1.36$7.00Buy$0.0000.00% ROITRMLTourmaline Bio5/5/2025Reiterated Rating$16.30$50.00Buy$0.0000.00% ROIBLCOBausch + Lomb5/2/2025Lower Price Target$11.59$15.00Buy$00.0000.00% ROIZYXIZynex4/30/2025Lower Price Target$2.23$8.00Buy$0.0000.00% ROILFMDLifeMD4/30/2025Reiterated Rating$8.62$14.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical4/29/2025Reiterated Rating$2.68$9.00Buy$0.0000.00% ROIGLSIGreenwich LifeSciences4/21/2025Boost Price Target$8.95$39.00Buy$00.0000.00% ROIOCSOculis4/17/2025Boost Price Target$18.02$32.00Buy$00.0000.00% ROIBNGOBionano Genomics4/9/2025Initiated Coverage$2.83$10.00Buy$0.0000.00% ROIVNRXVolitionRX4/8/2025Initiated Coverage$10.00$50.00Buy$0.0000.00% ROIANGOAngioDynamics4/7/2025Reiterated Rating$9.11$16.00Buy$0.0000.00% ROIOPKOPKO Health4/7/2025Reiterated Rating$1.53$3.00Buy$0.0000.00% ROIOBIOOrchestra BioMed4/4/2025Lower Price Target$3.11$12.00Buy$0.0000.00% ROIKALAKALA BIO4/4/2025Reiterated Rating$231.50$750.00Buy$0.0000.00% ROII was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public canSRTSSensus Healthcare4/4/2025Reiterated Rating$4.51$12.00Buy$0.0000.00% ROICLSDClearside Biomedical3/31/2025Reiterated Rating$14.25$90.00Buy$0.0000.00% ROIVRAXVirax Biolabs Group3/31/2025Initiated Coverage$1.16$3.00Buy$0.0000.00% ROIICCMIceCure Medical3/28/2025Reiterated Rating$1.11$2.50Buy$0.0000.00% ROIKPRXKiora Pharmaceuticals3/28/2025Reiterated Rating$3.02$10.00Buy$0.0000.00% ROICODXCo-Diagnostics3/28/2025Lower Price Target$9.72$30.00Neutral$0.0000.00% ROIANIXAnixa Biosciences3/25/2025Reiterated Rating$3.20$7.00Buy$0.0000.00% ROIBRNSBarinthus Biotherapeutics3/21/2025Reiterated Rating$1.01$3.00Buy$0.0000.00% ROIOPKOPKO Health3/19/2025Reiterated Rating$1.79$3.00Buy$0.0000.00% ROIBLTEBelite Bio3/18/2025Reiterated Rating$67.81$100.00Buy$000.0000.00% ROIDRTSAlpha Tau Medical3/17/2025Reiterated Rating$2.65$9.00Buy$0.0000.00% ROITRMLTourmaline Bio3/14/2025Boost Price Target$17.04$50.00Buy$0.0000.00% ROIOCSOculis3/13/2025Lower Price Target$18.84$29.00Buy$00.0000.00% ROILFMDLifeMD3/12/2025Boost Price Target$5.57$14.00Buy$0.0000.00% ROIZYXIZynex3/12/2025Lower Price Target$7.00$15.00Buy$0.0000.00% ROIOPKOPKO Health3/12/2025Reiterated Rating$1.77$3.00Buy$0.0000.00% ROIOBIOOrchestra BioMed3/10/2025Reiterated Rating$4.23$14.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/6/2025Reiterated Rating$6.58$22.00Buy$00.0000.00% ROICLSDClearside Biomedical3/6/2025Reiterated Rating$14.40$90.00Buy$0.0000.00% ROIOCULOcular Therapeutix3/4/2025Reiterated Rating$5.93$15.00Buy$00.0000.00% ROIOPKOPKO Health3/3/2025Reiterated Rating$1.74$3.00Buy$0.0000.00% ROICDNACareDx3/3/2025Lower Price Target$22.15$25.00Neutral$00.0000.00% ROIOKYOOKYO Pharma2/18/2025Reiterated Rating$1.10$7.00Buy$0.0000.00% ROIBLCOBausch + Lomb2/18/2025Reiterated Rating$16.44$23.00Buy$00.0000.00% ROIANIXAnixa Biosciences2/18/2025Reiterated Rating$3.06$7.00Buy$0.0000.00% ROIKALAKALA BIO2/13/2025Reiterated Rating$372.00$750.00Buy$00.0000.00% ROIGLSIGreenwich LifeSciences2/11/2025Reiterated Rating$12.25$38.00Buy$00.0000.00% ROISRTSSensus Healthcare2/10/2025Boost Price Target$5.84$12.00Buy$0.0000.00% ROIOKYOOKYO Pharma2/10/2025Reiterated Rating$1.14$7.00Buy$0.0000.00% ROIHROWHarrow2/6/2025Initiated Coverage$30.89$57.00Buy$00.0000.00% ROILEXXLexaria Bioscience1/24/2025Lower Price Target$1.82$7.00Buy$0.0000.00% ROIRGNXREGENXBIO1/15/2025Reiterated Rating$7.05$36.00Buy$00.0000.00% ROICDNACareDx1/14/2025Reiterated Rating$25.07$26.00Neutral$00.0000.00% ROIBRNSBarinthus Biotherapeutics1/13/2025Lower Price Target$1.03$3.00Buy$0.0000.00% ROIANGOAngioDynamics1/10/2025Boost Price Target$12.94$15.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
